DiviDrip · TARS

TARS — Tarsus Pharmaceuticals, Inc.

TARS is Tarsus Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $83.20. Market cap: $3.63B. Capital Quality Rank: 79/100 — Elite compounder.

Stock snapshot

Price$83.20
Market cap$3.63B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)79 / 100 · Elite compounder
ROIC (TTM)-24.1%
Revenue CAGR (3y)159.5%
Shareholder buyback yield-10.00%
Altman Z-score zoneSafe

About TARS

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Listed2020Employees370HQIrvine, CASectorHealthcareWebsitetarsusrx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TARS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TARS's current stock price?

TARS (Tarsus Pharmaceuticals, Inc.) is currently trading at $83.20.

Does TARS pay a dividend?

TARS (Tarsus Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is TARS's Capital Quality Rank?

TARS has a Capital Quality Rank of 79/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TARS in DiviDrip

Add TARS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow